Signal transduction in ischemic preconditioning

Advances in Experimental Medicine and Biology

Volumn 430, Issue , 1997, Pages 39-55

  Downey, James M ^a   Cohen, Michael V ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR; BRADYKININ RECEPTOR; OPIATE RECEPTOR; POTASSIUM CHANNEL; PROTEIN KINASE C;

ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DOG; HEART MUSCLE ISCHEMIA; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION;

ANIMALIA; CANIS FAMILIARIS; ORYCTOLAGUS CUNICULUS;

EID: 0030771885     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5959-7_4     Document Type: Article

References (78)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136.
2. Maroko PR, Kjekshus JK, Sobel BE, Watanabe T, Covell JW, Ross J Jr, Braunwald E. Factors influencing infarct size following experimental coronary artery occlusions. Circulation 1971;43:67-82.
3. Hearse DJ, Yellon DM, Downey JM. Can beta blockers limit myocardial infarct size? Eur Heart J 1986;7:925-930.
4. Reimer KA, Murry CE, Richard VJ. The role of neutrophils and free radicals in the ischemic-reperfused heart: why the confusion and controversy? J Mol Cell Cardiol 1989;21:1225-1239.
5. Kloner RA, Braunwald E. Effects of calcium antagonists on infarcting myocardium. Am J Cardiol 1987;59:84B-94B.
6. Turrens JF, Thornton J, Barnard ML, Snyder S, Liu O, Downey JM. Protection from reperfusion injury by preconditioning hearts does not involve increased antioxidant defenses. Am J Physiol 1992;262:H585-H589.
7. Murry CE, Richard VJ, Jennings RB, Reimer KA. Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Am J Physiol 1991;260:H796-H804.
8. Thornton J, Striplin S, Liu GS, Swafford A, Stanley AWH, Van Winkle DM, Downey JM. Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning. Am J Physiol 1990;259:H1822-H1825.
9. Schott RJ, Rohmann S, Braun ER, Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 1990;66:1133-1142.
10. ATP channel. Am J Physiol 1994;266:H829-H839.
11. Van Winkle DM, Thornton JD, Downey DM, Downey JM. The natural history of preconditioning: cardioprotection depends on duration of transient ischemia and time to subsequent ischemia. Coron Artery Dis 1991;2:613-619.
12. Yellon DM, Alkhulaifi AM, Browne EE, Pugsley WB. Ischaemic preconditioning limits infarct size in the rat heart. Cardiovasc Res 1992;26:983-987.
13. Li Y, Kloner RA. The cardioprotective effects of ischemic "preconditioning" are not mediated by adenosine receptors in rat hearts. Circulation 1993;87:1642-1648.
14. Liu Y, Downey JM. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol 1992;263:H1107-H1112.
15. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW Jr, Herrmann HC, Laskey WK. Adaptation to ischemia during percutaneous transluminal coronary angioplasty: clinical, hemodynamic, and metabolic features. Circulation 1990;82:2044-2051.
16. Walker DM, Walker JM, Pugsley WB, Pattison CW, Yellon DM. Preconditioning in isolated superfused human muscle. J Mol Cell Cardiol 1995;27:1349-1357.
17. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet 1993;342:276-277.
18. Ikonomidis JS, Shirai T, Weisel RD, Derylo B, Rao V, Whiteside CI, Mickle DAG, Li R-K. "Ischemic" or adenosine preconditioning of human ventricular cardiomyocytes is protein kinase C dependent. Circulation 1995;92 (Suppl I):I-12. Abstract.
19. Li GC, Vasquez JA, Gallagher KP, Lucchesi BR. Myocardial protection with preconditioning. Circulation 1990;82:609-619.
20. Miura T, Adachi T, Ogawa T, Iwamoto T, Tsuchida A, Iimura O. Myocardial infarct size-limiting effect of ischemic preconditioning: its natural decay and the effect of repetitive preconditioning. Cardiovasc Pathol 1992;1:147-154.
21. 1 adenosine receptors in rabbit heart. Circulation 1991;84:350-356.
22. Tsuchida A, Miura T, Miki T, Shimamoto K, Iimura O. Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning. Cardiovasc Res 1992;26:456-461.
23. Schulz R, Rose J, Post H, Heusch G. Involvement of endogenous adenosine in ischaemic preconditioning in swine. Pflügers Arch 1995;430:273-282.
24. Schwarz ER, Mohri M, Sack S, Arras M. The role of adenosine and ils A1-receptor in ischemic preconditioning. Circulation 1991;84(Suppl II):II-191. Abstract.
25. ATP channels and ischemic preconditioning in dogs. Am J Physiol 1993;264:H1327-H1336.
26. Kerensky RA, Kutcher MA, Braden GA, Applegate RJ, Sous GA, Little WC. The effects of intracoronary adenosine on preconditioning during coronary angioplasty. Clin Cardiol 1995;18:91-96.
27. 6-phenyl-isopropyladenosine on myocardial inositol phosphate content and force of contraction. Br J Pharmacol 1990;101:829-834.
28. Cohen MV, Liu Y, Liu GS, Wang P, Weinbrenner C, Cordis GA, Das DK, Downey JM. Phospholipase D plays a role in ischemic preconditioning in rabbit heart. Circulation 1996;94:1713-1718.
29. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994;266:H1145-H1152.
30. Liu Y, Cohen MV, Downey JM. Chelerythrine, a highly selective protein kinase C inhibitor, blocks the antiinfarct effect of ischemic preconditioning in rabbit hearts. Cardiovasc Drugs Ther 1994;8:881-882.
31. Goto M, Liu Y, Yang X-M, Ardell JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 1995;77:611-621.
32. 1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res 1994;75:576-585.
33. Wang P, Gallagher KP, Downey JM, Cohen MV. Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart. J Mol Cell Cardiol 1996;28:579-588.
34. Liu Y, Tsuchida A, Cohen MV, Downey JM. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol 1995;27:883-892.
35. Miki T, Sato H, Cohen MV, Downey JM. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Circulation 1996;94 (Suppl I):I-392-I-393. Abstract.
36. Natarajan V, Taher MM, Roehm H, Parinandi NL, Schmid HHO, Kiss Z, Garcia JGN. Activation of endothelial cell phospholipase D by hydrogen peroxide and fatty acid hydroperoxide. J Biol Chem 1993;268:930-937.
37. 2+- and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc Natl Acad Sci 1989;86:6758-6762.
38. Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 1997;29:207-216.
39. Schultz JEJ, Rose E, Yao Z, Gross GJ. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 1995;268:H2157-H2161.
40. Cohen MV, Walsh RS, Goto M, Downey JM. Hypoxia preconditions rabbit myocardium via adenosine and catecholamine release. J Mol Cell Cardiol 1995;27:1527-1534.
41. Yang X-M, Sato H, Downey JM, Cohen MV. Protection of ischemic preconditioning is dependent upon a critical timing sequence of protein kinase C activation. J Mol Cell Cardiol 1997; in press.
42. Thornton JD, Thornton CS, Downey JM. Effect of adenosine receptor blockade: preventing protective preconditioning depends on time of initiation. Am J Physiol 1993;265:H504-H508.
43. Cohen MV, Downey JM. Ischaemic preconditioning: can the protection be bottled? Lancet 1993;342:6.
44. Liu Y, Ytrehus K, Downey JM. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 1994;26:661-668.
45. Armstrong SC, Hoover DB, DeLacey MH, Ganote CE. Translocation of PKC, protein phosphatase inhibition and preconditioning of rabbit cardiomyocytes. J Mol Cell Cardiol 1996;28:1479-1492.
46. Brooks G, Hearse DJ. Role of protein kinase C in ischemic preconditioning: player or spectator? Circ Res 1996;79:627-630.
47. Van Wylen DGL. Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation 1994;89:2283-2289.
48. Goto M, Cohen MV, Van Wylen DGL, Downey JM. Attenuated purine production during subsequent ischemia in preconditioned rabbit myocardium is unrelated to the mechanism of protection. J Mol Cell Cardiol 1996;28:447-454.
49. Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992;70:223-233.
50. ATP channels, and ischemic preconditioning in dogs. Am J Physiol 1993;264:H1327-H1336.
51. + channel activation does not mediate preconditioning in isolated rat hearts. Circulation 1992;86 (Suppl I):I-341. Abstract.
52. Schultz JEJ, Hsu AK, Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 1996;78:1100-1104.
53. Thornton JD, Thornton CS, Sterling DL, Downey JM. Blockade of ATP-sensitive potassium channels increases infarct size hut does not prevent preconditioning in rabbit hearts. Circ Res 1993;72:44-49.
54. ATP channel antagonist to attenuate preconditioning in rabbit myocardium. Cardiovasc Res 1994;28:1337-1341.
55. Armstrong S, Ganote CE. Preconditioning of isolated rabbit cardiomyocytes: effects of glycolytic blockade, phorbol esters, and ischaemia. Cardiovasc Res 1994;28:1700-1706.
56. Murry CE, Richard VJ, Reimer KA, Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 1990;66:913-931.
57. Kolocassides KG, Galiñanes M, Hearse DJ. Preconditioning accelerates contracture and ATP depletion in blood-perfused rat hearts. Am J Physiol 1995;269:H1415-H1420.
58. 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5′-nucleotidase activity. J Clin Invest 1994;93:2197-2205.
59. Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C: its role in ischemic preconditioning in the rat. Circ Res 1994;75:586-590.
60. Li Y, Kloner RA. Does protein kinase C play a role in ischemic preconditioning in rat heads? Am J Physiol 1995;268:H426-H431.
61. Mitchell MB, Meng X, Ao L, Brown JM, Harken AH, Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 1995;76:73-81.
62. 1B-adrenoceptors, pertussis toxin-sensitive G proteins, and protein kinase C. Circulation 1995;92:2259-2265.
63. Cave AC, Apstein CS. Polymyxin B, a protein kinase C inhibitor, abolishes preconditioning-induced protection against contractile dysfunction in the isolated blood perfused vat heart. J Mol Cell Cardiol 1996;28:977-987.
64. Brew EC, Mitchell MB, Rehring TF, Gamboni-Robertson F, McIntyre RC Jr, Harken AH, Banerjee A. Role of bradykinin in cardiac functional protection after global ischemia-reperfusion in rat heart. Am J Physiol 1995;269:H1370-H1378.
65. 1 receptor agonist was blocked by staurosporine. J Mol Cell Cardiol 1994;26:CLII. Abstract.
66. Armstrong S, Downey JM, Ganote CE. Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor. Cardiovasc Res 1994;28:72-77.
67. + channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circ Res 1995;77:1030-1035.
68. Tsuchida A, Miura T, Miki T, Sakamoto J, Iimura O. Role of α1-adrenergic receptor and protein kinase C in infarct size limitation by ischemic preconditioning in rat heart. Circulation 1994;90 (Suppl I):I-647. Abstract.
69. Kolocassides KG, Galiñanes M. The specific protein kinase C inhibitor chelerythrine fails to inhibit ischemic preconditioning in the rat heart. Circulation 1994;90 (Suppl I):I-208. Abstract.
70. Mitchell MB, Brew EC, Harken AH, Banerjee A. Does protein kinase C mediate functional preconditioning? J Mol Cell Cardiol 1993;25(Suppl III):S.64. Abstract.
71. 1-adrenergic signal transduction pathway or protein kinase C in the isolated rat heart. Cardiovasc Drugs Ther 1996;10:125-136.
72. Galiñanes M, McGill C, Brooks G, Hearse DJ. Can the protein kinase C activator diacylglycerol precondition the rat heart? J Mol Cell Cardiol 1996;28:A73. Abstract.
73. Kitakaze M, Node K, Minamino T, Komamura K, Funaya H, Shinozaki Y, Chujo M, Mori H, Inoue M, Hori M, Kamada T. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5′-nucleotidase. Circulation 1996;93:781-791.
74. Przyklenk K, Sussman MA, Simkhovich BZ, Kloner RA. Does ischemic preconditioning trigger translocal ion of protein kinase C in the canine model? Circulation 1995;92:1546-1557.
75. Vogt A, Barancik M, Weihrauch D, Arras M, Podzuweit T, Schaper W. Protein kinase C inhibitors reduce infarct size in pig hearts in vivo. Circulation 1994;90 (Suppl I):I-647. Abstract.
76. Vogt A, Barancik M, Weihrauch D, Arras M, Podzuweit T, Schaper W. Activation of protein kinase C fails to protect ischemic porcine myocardium from infarction in vivo. J Mol Cell Cardiol 1994;26:CXVIII. Abstract.
77. Vahlhaus C, Schulz R, Post H, Onallah R, Heusch G. No prevention of ischemic preconditioning by the protein kinase C inhibitor staurosporine in swine. Circ Res 1996;79:407-414.
78. Baines CP, Cohen MV, Downey JM. Protein tyrosine kinase inhibitor, genistein, blocks preconditioning in isolated rabbit hearts. Circulation 1996;94 (Suppl I):I-661. Abstract.